SOCS3–microtubule interaction via CLIP-170 and CLASP2 is critical for modulation of endothelial inflammation and lung injury

Proinflammatory cytokines such as IL-6 induce endothelial cell (EC) barrier disruption and trigger an inflammatory response in part by activating the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway. The protein suppressor of cytokine signaling-3 (SOCS3) is a negative regulator of JAK-STAT, but its role in modulation of lung EC barrier dysfunction caused by bacterial pathogens has not been investigated. Using human lung ECs and EC-specific SOCS3 knockout mice, we tested the hypothesis that SOCS3 confers microtubule (MT)-mediated protection against endothelial dysfunction. SOCS3 knockdown in cultured ECs or EC-specific SOCS3 knockout in mice resulted in exacerbated lung injury characterized by increased permeability and inflammation in response to IL-6 or heat-killed Staphylococcus aureus (HKSA). Ectopic expression of SOCS3 attenuated HKSA-induced EC dysfunction, and this effect required assembled MTs. SOCS3 was enriched in the MT fractions, and treatment with HKSA disrupted SOCS3–MT association. We discovered that—in addition to its known partners gp130 and JAK2—SOCS3 interacts with MT plus-end binding proteins CLIP-170 and CLASP2 via its N-terminal domain. The resulting SOCS3–CLIP-170/CLASP2 complex was essential for maximal SOCS3 anti-inflammatory effects. Both IL-6 and HKSA promoted MT disassembly and disrupted SOCS3 interaction with CLIP-170 and CLASP2. Moreover, knockdown of CLIP-170 or CLASP2 impaired SOCS3–JAK2 interaction and abolished the anti-inflammatory effects of SOCS3. Together, these findings demonstrate for the first time an interaction between SOCS3 and CLIP-170/CLASP2 and reveal that this interaction is essential to the protective effects of SOCS3 in lung endothelium.

[1]  A. Birukova,et al.  Staphylococcus aureus–induced endothelial permeability and inflammation are mediated by microtubule destabilization , 2019, The Journal of Biological Chemistry.

[2]  A. Birukova,et al.  Microtubule destabilization caused by particulate matter contributes to lung endothelial barrier dysfunction and inflammation. , 2019, Cellular signalling.

[3]  K. Slep,et al.  Mapping multivalency in the CLIP-170–EB1 microtubule plus-end complex , 2018, The Journal of Biological Chemistry.

[4]  Yina Liu,et al.  Unfractionated heparin ameliorates pulmonary microvascular endothelial barrier dysfunction via microtubule stabilization in acute lung injury , 2018, Respiratory Research.

[5]  J. Donato,et al.  SOCS3 as a future target to treat metabolic disorders , 2018, Hormones.

[6]  Wenjun Zhou,et al.  Lack of SOCS3 increases LPS-induced murine acute lung injury through modulation of Ly6C(+) macrophages , 2017, Respiratory Research.

[7]  Y. Leng,et al.  Protective effects of SOCS3 overexpression in high glucose-induced lung epithelial cell injury through the JAK2/STAT3 pathway , 2017, Molecular medicine reports.

[8]  S. Shetty,et al.  Selective HDAC6 inhibition prevents TNF-α-induced lung endothelial cell barrier disruption and endotoxin-induced pulmonary edema. , 2016, American journal of physiology. Lung cellular and molecular physiology.

[9]  Junsuk Ko,et al.  Cigarette Smoke Disrupted Lung Endothelial Barrier Integrity and Increased Susceptibility to Acute Lung Injury via Histone Deacetylase 6. , 2016, American journal of respiratory cell and molecular biology.

[10]  Y. Zhang,et al.  Preconditioning of physiological cyclic stretch attenuated HMGB1 expression in pathologically mechanical stretch-activated A549 cells and ventilator-induced lung injury rats through inhibition of IL-6/STAT3/SOCS3. , 2016, International immunopharmacology.

[11]  A. Birukova,et al.  Hepatocyte growth factor triggers distinct mechanisms of Asef and Tiam1 activation to induce endothelial barrier enhancement. , 2014, Cellular signalling.

[12]  Toshio Tanaka,et al.  IL-6 in inflammation, immunity, and disease. , 2014, Cold Spring Harbor perspectives in biology.

[13]  I. Alieva.  Role of microtubule cytoskeleton in regulation of endothelial barrier function , 2014, Biochemistry (Moscow).

[14]  A. Birukova,et al.  IQGAP1 Regulates Endothelial Barrier Function via EB1-Cortactin Cross Talk , 2014, Molecular and Cellular Biology.

[15]  M. Rottenberg,et al.  SOCS3, a Major Regulator of Infection and Inflammation , 2014, Front. Immunol..

[16]  A. Verin,et al.  The leading role of microtubules in endothelial barrier dysfunction: Disassembly of peripheral microtubules leaves behind the cytoskeletal reorganization , 2013, Journal of cellular biochemistry.

[17]  C. White,et al.  SOCS3: An essential physiological inhibitor of signaling by interleukin-6 and G-CSF family cytokines. , 2013, JAK-STAT.

[18]  A. Birukova,et al.  Measurement of local permeability at subcellular level in cell models of agonist- and ventilator-induced lung injury , 2013, Laboratory Investigation.

[19]  A. Birukova,et al.  Oxidative stress contributes to lung injury and barrier dysfunction via microtubule destabilization. , 2012, American journal of respiratory cell and molecular biology.

[20]  R. Norton,et al.  Suppression of cytokine signaling by SOCS3: characterization of the mode of inhibition and the basis of its specificity. , 2012, Immunity.

[21]  M. Merchant,et al.  Signaling via the prostaglandin E₂ receptor EP4 exerts neuronal and vascular protection in a mouse model of cerebral ischemia. , 2011, The Journal of clinical investigation.

[22]  J. Pfeilschifter,et al.  Protective properties of inhaled IL-22 in a model of ventilator-induced lung injury. , 2011, American journal of respiratory cell and molecular biology.

[23]  N. Galjart,et al.  Phosphorylation of CLASP2 by GSK-3β regulates its interaction with IQGAP1, EB1 and microtubules , 2009, Journal of Cell Science.

[24]  R. Norton,et al.  The SOCS box encodes a hierarchy of affinities for Cullin5: implications for ubiquitin ligase formation and cytokine signalling suppression. , 2009, Journal of molecular biology.

[25]  A. Birukova,et al.  Amifostine reduces lung vascular permeability via suppression of inflammatory signalling , 2009, European Respiratory Journal.

[26]  Yingle Liu,et al.  The role of microtubule‐associated protein 1S in SOCS3 regulation of IL‐6 signaling , 2008, FEBS letters.

[27]  A. Dolganiuc,et al.  Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytes. , 2008, Alcoholism, clinical and experimental research.

[28]  N. Maniatis,et al.  The endothelium in acute lung injury/acute respiratory distress syndrome , 2008, Current opinion in critical care.

[29]  W. Alexander,et al.  The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo. , 2007, Blood.

[30]  P. Ward,et al.  STAT3 and suppressor of cytokine signaling 3: potential targets in lung inflammatory responses , 2007, Expert opinion on therapeutic targets.

[31]  Masato Kubo,et al.  SOCS proteins, cytokine signalling and immune regulation , 2007, Nature Reviews Immunology.

[32]  Jackelyn A. Alva,et al.  VE‐cadherin‐CreERT2 transgenic mouse: A model for inducible recombination in the endothelium , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[33]  S. Hubbard,et al.  Structural basis for phosphotyrosine recognition by suppressor of cytokine signaling-3. , 2006, Structure.

[34]  A. Yoshimura,et al.  Divergent Mechanisms Utilized by SOCS3 to Mediate Interleukin-10 Inhibition of Tumor Necrosis Factor α and Nitric Oxide Production by Macrophages* , 2006, Journal of Biological Chemistry.

[35]  G. Bokoch,et al.  GEF-H1 is involved in agonist-induced human pulmonary endothelial barrier dysfunction. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[36]  J. Garcia,et al.  Involvement of microtubules and Rho pathway in TGF‐β1‐induced lung vascular barrier dysfunction , 2005, Journal of cellular physiology.

[37]  K. Kaibuchi,et al.  IQGAP1: a key regulator of adhesion and migration , 2005, Journal of Cell Science.

[38]  Kozo Kaibuchi,et al.  Novel role of microtubules in thrombin‐induced endothelial barrier dysfunction , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  C. Horvath.  The Jak-STAT Pathway Stimulated by Interleukin 6 , 2004, Science's STKE.

[40]  F. Liu,et al.  Microtubule disassembly induces cytoskeletal remodeling and lung vascular barrier dysfunction: Role of Rho‐dependent mechanisms , 2004, Journal of cellular physiology.

[41]  P. Ganz,et al.  Role of Endothelial Dysfunction in Atherosclerosis , 2004, Circulation.

[42]  D. Harrison,et al.  The JAK/STAT signaling pathway , 2004, Journal of Cell Science.

[43]  S. Ye,et al.  Magnitude-dependent regulation of pulmonary endothelial cell barrier function by cyclic stretch. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[44]  S. Akira,et al.  IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages , 2003, Nature Immunology.

[45]  J. Garcia,et al.  The role of the microtubules in tumor necrosis factor-α-induced endothelial cell permeability , 2003 .

[46]  S. Kuroda,et al.  Rac1 and Cdc42 Capture Microtubules through IQGAP1 and CLIP-170 , 2002, Cell.

[47]  Warren S. Alexander,et al.  Suppressors of cytokine signalling (SOCS) in the immune system , 2002, Nature Reviews Immunology.

[48]  W. Alexander,et al.  Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[49]  D. Hilton,et al.  SOCS: physiological suppressors of cytokine signaling. , 2000, Journal of cell science.

[50]  W. Leonard,et al.  Cytokine receptor signaling pathways. , 2000, The Journal of allergy and clinical immunology.

[51]  P. Heinrich,et al.  SOCS3 Exerts Its Inhibitory Function on Interleukin-6 Signal Transduction through the SHP2 Recruitment Site of gp130* , 2000, The Journal of Biological Chemistry.

[52]  H. Pendeville,et al.  SOCS3 Is Essential in the Regulation of Fetal Liver Erythropoiesis , 1999, Cell.

[53]  J. Johnston,et al.  Cytokine‐inducible SH2 protein‐3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N‐terminal kinase inhibitory region as well as SH2 domain , 1999, Genes to cells : devoted to molecular & cellular mechanisms.

[54]  J. G. Zhang,et al.  The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Warren S. Alexander,et al.  A family of cytokine-inducible inhibitors of signalling , 1997, Nature.

[56]  N. Smith,et al.  IL‐6 acts on endothelial cells to preferentially increase their adherence for lymphocytes , 1996, Clinical and experimental immunology.

[57]  A. Waage,et al.  Cytokine regulation of interleukin 6 production by human endothelial cells. , 1989, Cellular immunology.

[58]  A. Birukova,et al.  Role of microtubules in attenuation of PepG-induced vascular endothelial dysfunction by atrial natriuretic peptide. , 2015, Biochimica et biophysica acta.

[59]  J. Garcia,et al.  The role of the microtubules in tumor necrosis factor-alpha-induced endothelial cell permeability. , 2003, American journal of respiratory cell and molecular biology.